Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricardo Galler

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Hybridoma (2005)|June 13, 2009
Generation of monoclonal antibodies against human recombinant interferon beta using genetic immunization with simultaneous expression of IgM and IgG isotypesCarina Pacheco Cantelli, Maria da Glória Martins Teixeira, Eneida Almeida Santos, et al.
Journal of Virology|January 22, 2010
Recombinant yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 gag induces SIV-specific CD8+ T-cell responses in rhesus macaquesMyrna C Bonaldo, Mauricio A Martins, Richard Rudersdorf, et al.
Plos Neglected Tropical Diseases|April 16, 2015
A DNA vaccine against yellow fever virus: development and evaluationMilton Maciel, Fábia da Silva Pereira Cruz, Marli Tenório Cordeiro, et al.
Revista Da Sociedade Brasileira De Medicina Tropical|December 14, 2004
Yellow fever virus isolated from a fatal post vaccination event: an experimental comparative study with the 17DD vaccine strain in the Syrian hamster (Mesocricetus auratus)Sueli Guerreiro Rodrigues, Amélia Paes de Andrade Travassos da Rosa, Ricardo Galler, et al.
Journal of Virology|April 18, 2014
Vaccination with Gag, Vif, and Nef gene fragments affords partial control of viral replication after mucosal challenge with SIVmac239Mauricio A Martins, Nancy A Wilson, Shari M Piaskowski, et al.
Plos One|January 22, 2013
Immunogenicity of seven new recombinant yellow fever viruses 17D expressing fragments of SIVmac239 Gag, Nef, and Vif in Indian rhesus macaquesMauricio A Martins, Myrna C Bonaldo, Richard A Rudersdorf, et al.
Clinical and Vaccine Immunology : CVI|November 13, 2009
Clinical and immunological insights on severe, adverse neurotropic and viscerotropic disease following 17D yellow fever vaccinationMaria Luiza Silva, Luçandra Ramos Espírito-Santo, Marina Angela Martins, et al.
Human Vaccines & Immunotherapeutics|February 1, 2013
17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response studyReinaldo M Martins, Maria de Lourdes S Maia, Roberto Henrique G Farias, et al.
Journal of Virology|August 21, 2015
Vaccine-Induced Simian Immunodeficiency Virus-Specific CD8+ T-Cell Responses Focused on a Single Nef Epitope Select for Escape Variants Shortly after InfectionMauricio A Martins, Damien C Tully, Michael A Cruz, et al.
Plos One|September 3, 2011
GagCM9-specific CD8+ T cells expressing limited public TCR clonotypes do not suppress SIV replication in vivoLara Vojnov, Mauricio A Martins, Jorge R Almeida, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Hybridoma (2005)|June 13, 2009
Generation of monoclonal antibodies against human recombinant interferon beta using genetic immunization with simultaneous expression of IgM and IgG isotypesCarina Pacheco Cantelli, Maria da Glória Martins Teixeira, Eneida Almeida Santos, et al.
Journal of Virology|January 22, 2010
Recombinant yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 gag induces SIV-specific CD8+ T-cell responses in rhesus macaquesMyrna C Bonaldo, Mauricio A Martins, Richard Rudersdorf, et al.
Plos Neglected Tropical Diseases|April 16, 2015
A DNA vaccine against yellow fever virus: development and evaluationMilton Maciel, Fábia da Silva Pereira Cruz, Marli Tenório Cordeiro, et al.
Revista Da Sociedade Brasileira De Medicina Tropical|December 14, 2004
Yellow fever virus isolated from a fatal post vaccination event: an experimental comparative study with the 17DD vaccine strain in the Syrian hamster (Mesocricetus auratus)Sueli Guerreiro Rodrigues, Amélia Paes de Andrade Travassos da Rosa, Ricardo Galler, et al.
Journal of Virology|April 18, 2014
Vaccination with Gag, Vif, and Nef gene fragments affords partial control of viral replication after mucosal challenge with SIVmac239Mauricio A Martins, Nancy A Wilson, Shari M Piaskowski, et al.
Plos One|January 22, 2013
Immunogenicity of seven new recombinant yellow fever viruses 17D expressing fragments of SIVmac239 Gag, Nef, and Vif in Indian rhesus macaquesMauricio A Martins, Myrna C Bonaldo, Richard A Rudersdorf, et al.
Clinical and Vaccine Immunology : CVI|November 13, 2009
Clinical and immunological insights on severe, adverse neurotropic and viscerotropic disease following 17D yellow fever vaccinationMaria Luiza Silva, Luçandra Ramos Espírito-Santo, Marina Angela Martins, et al.
Human Vaccines & Immunotherapeutics|February 1, 2013
17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response studyReinaldo M Martins, Maria de Lourdes S Maia, Roberto Henrique G Farias, et al.
Journal of Virology|August 21, 2015
Vaccine-Induced Simian Immunodeficiency Virus-Specific CD8+ T-Cell Responses Focused on a Single Nef Epitope Select for Escape Variants Shortly after InfectionMauricio A Martins, Damien C Tully, Michael A Cruz, et al.
Plos One|September 3, 2011
GagCM9-specific CD8+ T cells expressing limited public TCR clonotypes do not suppress SIV replication in vivoLara Vojnov, Mauricio A Martins, Jorge R Almeida, et al.
Pageof 6